Brief hiatus in baricitinib therapy led to minor RA symptom recurrence
Healio.com,
2 min read Source/Disclosures Disclosures: Emery reports consulting fees from Pfizer, MSD, AbbVie, Bristol-Myers Squibb, UCB…
2 min read Source/Disclosures Disclosures: Emery reports consulting fees from Pfizer, MSD, AbbVie, Bristol-Myers Squibb, UCB…
medwireNews: Brief interruptions are common among people receiving baricitinib for rheumatoid arthritis (RA) and are associated…